International Cardio-Oncology Society (ICOS) shared a post on LinkedIn:
“Did you know that some cancer treatments can affect the heart – even before the final round of chemotherapy is complete?
Cardiotoxicity is an underrecognized challenge in cancer care. It can present as a drop in heart function, new arrhythmias, hypertension, or accelerated coronary disease – and in many cases, it develops silently, without symptoms, until it becomes difficult to reverse.
The good news: when caught early, many forms of treatment-related cardiac injury can be managed, mitigated, or even prevented entirely.
That is exactly why cardio-oncology exists.
Our specialty combines the expertise of cardiology and oncology to monitor, protect, and support the heart throughout cancer treatment and survivorship – so that patients can receive the care they need without sacrificing cardiovascular health.
We’re committed to spreading this message far and wide. Every patient deserves to know their options.”
Other articles feautirng International Cardio-Oncology Society on OncoDaily.